Medication info
Sitadion Tablet 100/30mg (Sitagliptin Phosphate Hydrate, Pioglitazone Hydrochloride)

Sitadion Tablet 100/30mg (Sitagliptin Phosphate Hydrate, Pioglitazone Hydrochloride)

Prescription medicationTablet
Ingredient · strength
Sitagliptin Phosphate Hydrate›128.5mg / 1 tabletPioglitazone Hydrochloride›33.06mg / 1 tablet
Manufacturer / importer
(주)마더스제약
Appearance
Yellow elliptical film-coated tablet
Packaging
Bottle packaging - 30 tablets/bottle, Bottle packaging - 100 tablets/bottle
Approval status
Active

MFDS item code 202302357 · Approved 2023.08.08 · Insurance code 622805090

Summary

Main use
Improvement of blood sugar control in type 2 diabetes
Who uses it
Adults
Adult dosage
For adults, this medication may be administered as 1 tablet daily without regard to meals to patients with type 2 diabetes receiving a combination of 100mg sitagliptin and 15mg or 30mg pioglitazone.

Ingredients

Manufacturer
(주)마더스제약

Efficacy & effects

Improvement of blood sugar control in type 2 diabetes

View approved original text

This medication is used as an adjunct to dietary and exercise therapy to help improve blood sugar control in patients with type 2 diabetes who are suitable for combined treatment with sitagliptin and pioglitazone. In other words, it helps effectively manage blood sugar levels to aid in diabetes treatment.

Dosage and Administration

Adult dosage

For adults, this medication may be administered as 1 tablet daily without regard to meals to patients with type 2 diabetes receiving a combination of 100mg sitagliptin and 15mg or 30mg pioglitazone.

Precautions

This medication contains two ingredients, sitagliptin and pioglitazone. First, the sitagliptin component may rarely cause serious allergic reactions, so if symptoms such as skin rash, hives, or difficulty breathing occur after taking the medication, you should stop taking it immediately and consult a doctor. Also, sitagliptin may carry a risk of causing pancreatitis, so if you experience abdominal pain, vomiting, or loss of appetite while taking it, you should inform a healthcare provider immediately. The pioglitazone component can exacerbate or cause heart failure, so patients with heart failure or those with a history of heart failure should not take this medication, and symptoms of heart failure such as weight gain, shortness of breath, and leg swelling should be vigilantly monitored during treatment. This medication should not be administered to patients with active bladder cancer or a previous history of bladder cancer, and if symptoms such as hematuria or urgency occur during urination, you should notify a doctor immediately. Patients with severely impaired kidney function should not take this medication, and those with slightly impaired kidney function should have dosage adjustments as needed, with regular kidney function tests recommended. Pregnant women or those who may become pregnant should not take this medication, and premenopausal women should take appropriate contraceptive measures to prevent pregnancy. While taking this medication, you should pay attention to symptoms of hypoglycemia, as the risk of hypoglycemia may increase when combined with other diabetes medications. Additionally, this medication may cause edema and weight gain, so if these symptoms occur, you should consult a healthcare provider. Rarely, symptoms of abnormal liver function and liver failure have been reported, so if you experience symptoms indicative of liver damage such as fatigue, jaundice, or abdominal pain, you should seek medical attention immediately. Finally, this medication may increase the risk of fractures, so especially female patients should pay attention to bone health and receive appropriate tests as needed.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe hypersensitivity reactions (anaphylaxis, angioedema, Stevens-Johnson syndrome, and exfoliative skin disease), acute pancreatitis (hemorrhagic or necrotizing pancreatitis, fatal/non-fatal), acute renal failure, severe and disabling joint pain, bullous pemphigoid, congestive heart failure and exacerbation of heart failure, jaundice (yellowing of the skin or eyes),

Mild side effects

  • Hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
  • diarrhea
  • nausea
  • constipation
  • abdominal bloating
  • indigestion
  • dizziness
Show 22 more
  • peripheral edema
  • myalgia
  • limb pain
  • back pain
  • increased serum creatinine
  • increased serum triglycerides
  • hypertension
  • weight gain
  • low back pain
  • elevated serum creatine kinase
  • sinusitis
  • thrombocytopenia
  • itching
  • eczema
  • joint pain
  • knee abnormalities
  • arm weakness
  • proteinuria
  • anxiety
  • insomnia
  • drowsiness
  • herpes simplex

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. By storing it this way, the efficacy of the medication can be maintained for a longer time.

Appearance and packaging

Appearance

Yellow elliptical film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.